Milestones and Payments. In consideration of Seller’s grant of the exclusive distribution rights hereunder to Purchaser, Purchaser shall pay Seller the following amounts upon completion of the applicable milestone:
Milestones and Payments. On a Regeneron Target-by-Regeneron Target basis, Regeneron shall pay Intellia the milestone payments set forth in the table below upon the first achievement by Regeneron of the corresponding milestone event set forth in the table below for the first Regeneron Product Directed to such Regeneron Target. For clarity, each milestone event (and the corresponding milestone payment) is payable only once with respect to a given Regeneron Target (even if the same milestone event is subsequently achieved again for the same Regeneron Target, whether by the same Regeneron Product Directed to such Regeneron Target or by a different Regeneron Product Directed to such Regeneron Target).
Milestones and Payments. LLS and Company agree to the following provisions regarding timelines, Milestones and Payments in performance of the Research Program under the terms of the Agreement. Milestones Payment Projected Bate [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**].
Milestones and Payments. 9.1 In consideration for the rights granted by Novartis to BMP in terms of this Agreement, BMP shall pay to Novartis under the following milestones:
Milestones and Payments. In consideration of Seller’s grant of the exclusive distribution rights hereunder to Purchaser, Purchaser shall pay Seller the sum of $4,500,000 upon the Effective Date of this Agreement.”
Milestones and Payments. EYETECH will make the following payments to ARCHEMIX upon the first achievement of the following milestone events with respect to each Compound or Back-Up, other than Compounds or Back-ups against VEGF: Payment Milestone (in U.S. Dollars)
Milestones and Payments. EYETECH and ARCHEMIX will each make the following payments to the other upon the first achievement by it of the following milestone events with respect to each VEGF Product : Payment Milestone (in US Dollars)
Milestones and Payments. LLS and Company agree to the following provisions regarding timelines, Milestones and Payments in performance of the Research Program under the terms of the Agreement. Milestones Payment Projected Date [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**]. EXHIBIT D Research Plan Project Title Development of [**], an inhibitor of BET protein bromodomains, for the treatment of patients with hematologic malignancies Project Descriptors Disease Diagnostic Group ☒ Lymphoma ☒ Leukemia ☒ Myeloma ☐ Other ☐ Not Assignable Specific Disease (if assignable) Patients with lymphoma, myeloma or acute leukemia Technology ☒ Small Molecule Therapeutic ☐ Delivery Technology ☐ Biological Therapeutics ☐ Medical Device ☐ Device/Diagnostic ☐ Other Current Stage of Project [**]. Target / Pathway / Mechanism of Action [**]. Total Funding Requested and Timeframe 7.5 million USD is requested. [**]. Summary Confidential Materials omitted and filed separately with the Securities and Exchange Commission. A total of 11 pages were omitted. [**] EXHIBIT E Report and RAC Meeting Schedules DELIVERABLE DUE DATE [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**]
Milestones and Payments. LLS and Affimed agree to the following provisions regarding Milestones and payments in performance of the AFM13 Development Program under the terms of the Agreement. Milestone Milestone Payment Milestone Event Projected Date M1 ***** ***** ***** M2 ***** ***** ***** M3 ***** ***** ***** M4 ***** ***** ***** M5* ***** ***** ***** M6* ***** ***** ***** M7* ***** ***** ***** All milestone payments shall become due and payable by LLS within ***** after LLS’ receipt of a written notice from Affimed confirming that the respective milestone event has occurred. * For clarification: Milestones M5 - M7 are each dependent on ***** as further described in the Affimed Proposal (Exhibit D). If no regimen *****, LLS reserves the right to make a No-go funding decision and cease all payments of Milestones M5 - M7. AMENDMENT TO EXHIBIT D AFM13 Proposal
Milestones and Payments. Milestone Number Milestone Description Deadline Payment 1 Execution of Agreement $53,267.00 2 Submission of report detailing activities and accomplishments April 6, 2019 $53,267.01 Note: Funds allocated as part of this Objective will be used to cover the Labor Trafficking Specialty Investigator’s salary, wages, and fringe benefits. Total Payment in USD: $106,534.01 OBJECTIVE 3: Hire, host, and manage a Rio Grande Valley/South Texas Anti-Human Trafficking Taskforce Coordinator to strengthen existing taskforce reach and expand services in the region Description: Awardee will create the position of full-time Rio Grande Valley/South Texas Anti- Human Trafficking Taskforce Coordinator and will advertise for, interview, and hire a qualified candidate to fill this role. The position will be funded full-time through March 2020. The responsibilities and duties of the Rio Grande Valley/South Texas Anti-Human Trafficking Taskforce Coordinator are listed below. Overall responsibilities With direction from Awardee and in consultation with the Xxxxxxx-XxXxxx Institute Initiative to Combat Modern Slavery Program Manager, the Rio Grande Valley/South Texas Taskforce Coordinator will work within the existing structure of the Rio Grande Valley Anti-Human Trafficking Taskforce (RGVAHTT) to strengthen existing taskforce reach and expand services to as many of the following counties in the Rio Grande Valley/South Texas regions as possible (also indicated on map below): Maverick, Zavala, Frio, Atascosa, Dimmit, La Salle, XxXxxxxx, Live Xxx, Xxxx, Xxxxx, Xxx Xxxxx, Xxxxxx, Xxx Xxxx, Xxxxxx, Xxxxx, Xxxxxxx, Xxxxxxx, and Xxxxxxx. Using the Office for Victims of Crime-Bureau of Justice Assistance Enhanced Collaborative Task Force model as a blueprint, the Coordinator will guide this task force to: Involve all relevant regional stakeholders, including, but not limited to o Law Enforcement Agencies Federal (e.g. Homeland Security Investigations, Federal Bureau of Investigation, Department of Labor, Department of Health and Human Services) State (e.g. Texas Department of Public Safety) Local (Sheriff’s Offices and municipal/town police departments) o Regulatory agencies (e.g. Texas Workforce Commission, Occupational Safety and Health Administration) o Prosecutorial authorities (U.S. Attorney’s Offices, District Attorney’s Offices) o Services organization (health services, social services, and legal aid) Crime victim services Migrant or immigrant services Worker advocacy...
